The overall goal of this project is to discover prototype lead compounds for development of new treatments for the major AIDS- and cancer-related disseminated fungal infections. Our approach is to evaluate previously unexamined and unique sources of natural products for in vitro activity against specific fungal pathogens and for their ability to reverse resistance to existing antifungal drugs, fractionate active extracts to isolate and identify pure active compounds, and determine the physicochemical properties, mechanisms of action, and toxicological profiles of the isolated active compounds.
The specific aims of this proposal are: 1) access a diverse and unique repository of extracts of plants, microbes, and invertebrate animals and prepare samples compatible with biological assays; 2) evaluate in vitro antifungal activity of the extracts for activity against Cryptococcus neoformans, Candida albicans, Candida glabrata, Candida kruseii and Aspergillus fumigatus, and for reversal of resistance to clinically available antifungal drugs; 3) isolate, elucidate the structures, and characterize the pharmaceutical properties of the active constituents; 4) characterize the biological properties of the active compounds using functional genomics, known antifungal enzymatic targets, and mammalian toxicological predictors. Successful completion of the proposed work will yield new prototype lead compounds that will serve as templates for development of new classes of antifungal agents, as templates for the development of new drugs to be used in combination with existing antifungal agents to reverse resistance to these agents, and as probes to identify novel mechanisms of action that can be exploited in the future search for other new derivatives.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI027094-13
Application #
6510407
Study Section
Special Emphasis Panel (ZRG1-AARR-3 (01))
Program Officer
Lambros, Chris
Project Start
1989-07-01
Project End
2004-02-28
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
13
Fiscal Year
2002
Total Cost
$251,125
Indirect Cost
Name
University of Mississippi
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
University
State
MS
Country
United States
Zip Code
38677
Shenmar, Kitika; Sharma, Krishna K; Wangoo, Nishima et al. (2017) Synthesis, stability and mechanistic studies of potent anticryptococcal hexapeptides. Eur J Med Chem 132:192-203
Tripathi, Siddharth K; Xu, Tao; Feng, Qin et al. (2017) Two plant-derived aporphinoid alkaloids exert their antifungal activity by disrupting mitochondrial iron-sulfur cluster biosynthesis. J Biol Chem 292:16578-16593
Ferreira, Mariana C; Cantrell, Charles L; Duke, Stephen O et al. (2017) New Pesticidal Diterpenoids from Vellozia gigantea (Velloziaceae), an Endemic Neotropical Plant Living in the Endangered Brazilian Biome Rupestrian Grasslands. Molecules 22:
Crockett, Sara L; Kunert, Olaf; Pferschy-Wenzig, Eva-Maria et al. (2016) Phloroglucinol and Terpenoid Derivatives from Hypericum cistifolium and H. galioides (Hypericaceae). Front Plant Sci 7:961
Gonçalves, Vívian N; Cantrell, Charles L; Wedge, David E et al. (2016) Fungi associated with rocks of the Atacama Desert: taxonomy, distribution, diversity, ecology and bioprospection for bioactive compounds. Environ Microbiol 18:232-45
Ravu, Ranga Rao; Jacob, Melissa R; Jeffries, Cynthia et al. (2015) LC-MS- and (1)H NMR Spectroscopy-Guided Identification of Antifungal Diterpenoids from Sagittaria latifolia. J Nat Prod 78:2255-9
Kushwaha, Avadhesh; Jacob, Melissa; Shiva Kumar, H N et al. (2015) Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm 41:1089-94
Moawad, Abeer; Hetta, Mona; Zjawiony, Jordan K et al. (2014) Two new dihydroamentoflavone glycosides from Cycas revoluta. Nat Prod Res 28:41-7
Ahmed, Marwa H; Ibrahim, Mohamed Ali; Zhang, Jin et al. (2014) Methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium active dimeric isobutyrylphloroglucinol from Ivesia gordonii. Nat Prod Commun 9:221-4
Falodun, Abiodun; Imieje, Vincent; Erharuyi, Osayewenre et al. (2014) Evaluation of three medicinal plant extracts against Plasmodium falciparum and selected microganisms. Afr J Tradit Complement Altern Med 11:142-6

Showing the most recent 10 out of 113 publications